Here are five things to know:
1. The initial products received FDA approval last year and include four interbody fusion systems:
•Nv(c): anterior cervical interbody fusion system
•Nv(t): transforaminal lumbar interbody fusion system
•Nv(p): posterior lumbar interbody fusion system
•Nv(a): anterior lumbar interbody fusion system
2. The devices have multiple footprints to adapt to the general shape of the vertebral endplates. The footprints are available in multiple heights to accommodate patient anatomy.
3. Nvision is committed to simplifying and improving surgical procedures with its products. The company has alignment with spine surgeons, researchers and development engineers to bring innovations to market.
4. The company has key supporting partnerships for an array of device and biologic technologies for surgeons and distributors in addition to developing its own products.
5. Brian Kieser founded Nvision in 2013 and the company boasts more than 100 years of combined experience and expertise in relationships.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
